Q1 2026 (Q&A)
Logotype for Advantest Corporation

Advantest (6857) Q1 2026 (Q&A) earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Advantest Corporation

Q1 2026 (Q&A) earnings summary

3 Feb, 2026

Executive summary

  • Achieved record-high quarterly sales, operating income, and net income in Q1 FY25, driven by robust AI-related demand and enhanced supply capabilities, with overseas sales accounting for 98.6% of total net sales.

  • Q1 was exceptionally strong due to significant pull-ins and higher-than-expected demand, especially in AI-related sectors, resulting in a record quarter for sales and profitability.

  • Raised full-year FY25 guidance following stronger-than-expected Q1, anticipating a temporary slowdown in 2H FY25 due to next-gen device transitions, with growth expected to reaccelerate in FY26 and optimism for 2027.

  • Q3 is expected to be the lowest quarter of the year, with sequential growth anticipated in Q4 and into FY 2026.

  • Overseas sales accounted for 98.6% of total net sales, reflecting robust global demand.

Financial highlights

  • Q1 FY25 sales reached JPY 263.8B, up 13.5% sequentially and 90.1% year-over-year, with gross profit at JPY 171.6B and gross margin improved to 65.1%.

  • Operating income rose to JPY 124.0B, operating margin at 47.0%, and net income surged to JPY 90.2B, net income margin at 34.2%.

  • Q1 operating income included a JPY 2.5B gain from partial business divestiture.

  • Basic earnings per share rose to JPY 123.14 from JPY 32.35 year-over-year.

  • Cash and cash equivalents increased to JPY 273.4B at quarter-end.

Outlook and guidance

  • Full-year sales forecast revised upward to JPY 835.0B, operating income to JPY 300.0B, and net income to JPY 221.5B, reflecting stronger-than-expected AI-related demand.

  • Q3 is projected as the bottom, with business expected to accelerate in Q4 and continue into 2026.

  • Guidance for the second half reflects strong Q1 pull-ins rather than a significant decline in demand.

  • R&D expenses for FY25 projected at JPY 76.5B, capital expenditure at JPY 26.0B.

  • Assumptions include USD/JPY at 140 and EUR/JPY at 155 for the remainder of the fiscal year.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more